Travaux scientifiques
Prof. Dr. Tevfik Fikret Çermik
200 publications. La source de l’information est indiquée à côté de chaque publication.
-
Dual-tracer Imaging of Chromophobe Renal Cell Carcinoma with [⁹⁹ᵐTC]TC-sestamibi and [⁶⁸GA]GA-DPI-4452
Nuclear Medicine and Molecular Imaging, 2026
DOI 10.1007/s13139-026-01086-5 Source : OpenAlex
-
Diagnostic Performance of 68 Ga DOTA-Pentixafor PET/CT in Benign Functional Adrenal Cortical Lesions
Clinical nuclear medicine, 2026
DOI 10.1097/rlu.0000000000006405 PMID 41941246 Source : Europe PMC
-
Clinical Value of 68 Ga-DOTA-Bombesin PET/CT Compared With 18 F-FDG PET/CT in the Staging of Breast Cancer
Clinical nuclear medicine, 2026
DOI 10.1097/rlu.0000000000006582 PMID 42305081 Texte intégral en libre accèsSource : Europe PMC
-
Comparative Performance of 68Ga-FAPI-04 and 18F-FDG PET/CT in Ovarian Cancer: Focus on Peritoneal Carcinomatosis
World Journal of Nuclear Medicine, 2026
DOI 10.1055/s-0046-1819631 PMID 42077575 Texte intégral en libre accèsSource : OpenAlex
-
Diagnostic and prognostic importance of 18F-fluorodeoxyglucose PET/computed tomography in primary extranodal and atypically presenting lymphomas
Nuclear Medicine Communications, 2026
DOI 10.1097/mnm.0000000000002096 PMID 41496608 1 citation (OpenAlex) Source : OpenAlex
-
From Metabolism to Molecular Phenotype: Carbonic Anhydrase IX–Targeted [ 68 Ga]Ga-DPI-4452 PET/CT in Renal Cell Carcinoma: A Prospective Multicenter Comparison with [ 18 F]FDG PET/CT
Journal of Nuclear Medicine, 2026
DOI 10.2967/jnumed.126.273011 PMID 42754347 1 citation (OpenAlex) Source : OpenAlex
-
One Tracer, Whole Syndrome
Clinical Nuclear Medicine, 2026
DOI 10.1097/rlu.0000000000006674 PMID 42779534 Source : OpenAlex
-
Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Brain Metastasis of Various Tumors Using Positron Emission Tomography?
Cancers, 2025
DOI 10.3390/cancers17183088 PMID 41008930 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
18F-FDG PET/CT Positive and 68Ga-DOTA-Bombesin PET/CT Negative Focus of Benign Apocrine Metaplasia Mimicking Malignancy
Clinical Nuclear Medicine, 2025
DOI 10.1097/rlu.0000000000005709 PMID 40025668 Source : OpenAlex
-
Calculation of recovery coefficients for partial volume effect correction in PET/CT imaging using a customized anthropomorphic body phantom
BioMedical Engineering OnLine, 2025
DOI 10.1186/s12938-025-01330-7 PMID 39955528 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Inflammatory 68Ga FAPI-46 Uptake Mimicking a Sister Mary Joseph’s Nodule in a Case of Gastric Signet Ring Cell Carcinoma
Clinical Nuclear Medicine, 2025
DOI 10.1097/rlu.0000000000005971 PMID 40361303 Source : OpenAlex
-
18F-FDG PET/CT and 68Ga-DOTATATE PET/CT Findings of Polycystic Kidney-derived Paraganglioma
Molecular imaging and radionuclide therapy, 2024
DOI 10.4274/mirt.galenos.2024.03264 PMID 39373189 Texte intégral en libre accèsSource : Europe PMC
-
Formulation and In-vivo Characterization of 177Lu-tin-colloid as a Radiosynovectomy Agent
Current radiopharmaceuticals, 2024
DOI 10.2174/0118744710252994231024064842 PMID 37937551 3 citations (Europe PMC) Source : Europe PMC
-
Detection of Rare Gallbladder Microperforation by 18F-FDG PET/CT in a Patient with Maxillary Sinus Cancer
Molecular imaging and radionuclide therapy, 2024
DOI 10.4274/mirt.galenos.2023.27576 PMID 38390789 Texte intégral en libre accèsSource : Europe PMC
-
Two Rare Benign Lesions on 18F-FDG PET/CT: Peliosis Hepatis and SANT
Molecular imaging and radionuclide therapy, 2024
DOI 10.4274/mirt.galenos.2023.02328 PMID 38390788 3 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC
-
Contribution of 68Ga-DOTA-FAPI-04 PET/CT to Prostate Cancer Imaging
Clinical Nuclear Medicine, 2024
DOI 10.1097/rlu.0000000000005064 PMID 38271254 18 citations (OpenAlex) Source : OpenAlex
-
The Contribution of 68Ga-FAPI-04 PET/CT to Staging and Prognosis in Gastric Cancer
Clinical Nuclear Medicine, 2024
DOI 10.1097/rlu.0000000000005394 PMID 39086038 18 citations (OpenAlex) Source : OpenAlex
-
Dual 177Lu–Prostate-Specific Membrane Antigen and 177Lu-DOTATATE Therapy in Metastatic Castration-Resistant Prostate Cancer With Neuroendocrine Differentiation
Clinical Nuclear Medicine, 2024
DOI 10.1097/rlu.0000000000005131 PMID 38409763 4 citations (OpenAlex) Source : OpenAlex
-
68Ga-DOTA-FAPI-46 PET/CT Imaging for Restaging in a Patient With Metastatic Pheochromocytoma
Clinical Nuclear Medicine, 2024
DOI 10.1097/rlu.0000000000005481 PMID 39365092 3 citations (OpenAlex) Source : OpenAlex
-
Physiological Gallbladder Accumulation on 68Ga-FAPI-46 PET/CT
Clinical Nuclear Medicine, 2024
DOI 10.1097/rlu.0000000000005480 PMID 39466623 2 citations (OpenAlex) Source : OpenAlex
-
Radiation Therapy–Induced Fibrous Histiocytoma, Mimicking Local Recurrence and Detected by 18F-FDG PET/CT in a Patient With Breast Cancer
Clinical Nuclear Medicine, 2024
DOI 10.1097/rlu.0000000000005320 PMID 38914095 1 citation (OpenAlex) Source : OpenAlex
-
18F-FDG PET/CT Imaging Findings in Adult-Onset Rasmussen Encephalitis
Clinical Nuclear Medicine, 2024
DOI 10.1097/rlu.0000000000005437 PMID 39325505 Source : OpenAlex
-
68Ga-NODAGA–Exendin-4 PET/CT Findings in a Case of Metastatic Insulinoma With Refractory Hypoglycemia Controlled by 90Y Transarterial Radioembolization
Clinical Nuclear Medicine, 2024
DOI 10.1097/rlu.0000000000005266 PMID 38967509 Source : OpenAlex
-
Bilateral Adrenal Metastasis of Prostatic Adenocarcinoma on 68Ga-PSMA PET/CT Imaging
Clinical Nuclear Medicine, 2024
DOI 10.1097/rlu.0000000000005248 PMID 38689449 1 citation (OpenAlex) Source : OpenAlex
-
The Importance of 18F-FDG PET/CT in a Rare Case of Multiple Myeloma Presenting With Nasal Plasmacytoma
Clinical Nuclear Medicine, 2024
DOI 10.1097/rlu.0000000000005546 PMID 39501469 1 citation (OpenAlex) Source : OpenAlex
-
Molecular Imaging in Stomach Malignancies
Nuclear Medicine Seminars, 2024
DOI 10.4274/nts.galenos.2024.0012 Texte intégral en libre accèsSource : OpenAlex
-
68Ga-FAPI-04 PET/CT in Selected Breast Cancer Patients With Low FDG Affinity A Head-to-Head Comparative Study
Clinical Nuclear Medicine, 2023
DOI 10.1097/rlu.0000000000004751 PMID 37351868 32 citations (Europe PMC) Source : ORCID
-
The roles of 68Ga-PSMA PET/CT and 18F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings
Nuclear Medicine Communications, 2023
DOI 10.1097/mnm.0000000000001663 PMID 36756767 10 citations (Europe PMC) Source : ORCID
-
Pneumonia with Intense 68Ga-FAPI Uptake Mimicking Metastasis on 68Ga-FAPI PET/CT in a Patient with Rectal Cancer
Molecular imaging and radionuclide therapy, 2023
DOI 10.4274/mirt.galenos.2023.07830 PMID 37870301 4 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC
-
Testicular Metastasis of Jejunal Neuroendocrine Tumor on 68Ga-DOTATATE PET/CT
Molecular imaging and radionuclide therapy, 2023
DOI 10.4274/mirt.galenos.2022.06926 PMID 37337848 2 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC
-
Findings of I-131 SPECT/CT, 18F-FDG, and 68Ga-FAPI-04 PET/CT Imaging in a Patient Treated with Radioiodine Therapy for Metastatic Papillary Thyroid Carcinoma
Molecular imaging and radionuclide therapy, 2023
DOI 10.4274/mirt.galenos.2022.02438 PMID 36819619 6 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC
-
68Ga-FAPI-04 PET/CT Findings in Patients with Liver Cirrhosis
Molecular imaging and radionuclide therapy, 2023
DOI 10.4274/mirt.galenos.2022.80774 PMID 37337827 9 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC
-
Cutaneous Metastase of Rectal Neuroendocrine Carcinoma Revealed on 18F-FDG PET/CT
Molecular imaging and radionuclide therapy, 2023
DOI 10.4274/mirt.galenos.2022.99266 PMID 37337847 Texte intégral en libre accèsSource : Europe PMC
-
Investigation of Clinical Histopathologic Features and Metabolic Parameters of 18F-FDG PET/CT in Invasive Breast Carcinoma with a Micropapillary Component
Molecular imaging and radionuclide therapy, 2023
DOI 10.4274/mirt.galenos.2023.06078 PMID 37870289 2 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC
-
68Ga-PSMA and 68Ga-FAPI-04 PET/CT Findings With 18F-FDG PET/CT in a Patient With Recurrent Prostate Cancer
Clinical Nuclear Medicine, 2023
DOI 10.1097/rlu.0000000000004522 PMID 36723899 9 citations (OpenAlex) Source : OpenAlex
-
The potential role of 68Ga-FAPI-04 PET/CT for screening malignancy in suspected colonic lesions
Nuclear Medicine Communications, 2023
DOI 10.1097/mnm.0000000000001734 PMID 37450605 8 citations (OpenAlex) Source : OpenAlex
-
A Comparison of 18F-FDG PET/CT and 68Ga-PSMA PET/CT in Detecting Osteonecrosis of the Jaw in a Patient With Prostate Cancer
Clinical Nuclear Medicine, 2023
DOI 10.1097/rlu.0000000000004970 PMID 38170920 7 citations (OpenAlex) Source : OpenAlex
-
68Ga-FAPI-04 PET/CT In Primary Signet Ring–Like Cell Carcinoma of Prostate With Bone Metastases
Clinical Nuclear Medicine, 2023
DOI 10.1097/rlu.0000000000004550 PMID 36728151 7 citations (OpenAlex) Source : OpenAlex
-
Effect of Leflunomide Use on 68Ga-DOTATATE Biodistribution in a Case With Neuroendocrine Tumor
Clinical Nuclear Medicine, 2023
DOI 10.1097/rlu.0000000000004517 PMID 36607376 3 citations (OpenAlex) Source : OpenAlex
-
68Ga-DOTA-FAPI-04 Imaging of Bilateral Phyllodes Tumor
Clinical Nuclear Medicine, 2023
DOI 10.1097/rlu.0000000000004782 PMID 37565817 3 citations (OpenAlex) Source : OpenAlex
-
68Ga-PSMA PET/CT Found Lower Respiratory Tract Inflammation Due to Inhaler Use
Clinical Nuclear Medicine, 2023
DOI 10.1097/rlu.0000000000005015 PMID 38170919 Source : OpenAlex
-
99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients
Annals of Nuclear Medicine, 2022
DOI 10.1007/s12149-022-01741-9 PMID 35426599 18 citations (Europe PMC) Source : OpenAlex
-
Comparison of 18F-FDG and 68Ga-FAPI PET/CT in Gastric Kaposi Sarcoma
Clinical Nuclear Medicine, 2022
DOI 10.1097/rlu.0000000000004172 PMID 35930714 5 citations (Europe PMC) Source : ORCID
-
Diagnostic impact of 18F-FDG PET/CT imaging on the detection of immune-related adverse events in patients treated with immunotherapy
Clinical and Translational Oncology, 2022
DOI 10.1007/s12094-022-02840-9 PMID 35594002 12 citations (Europe PMC) Source : ORCID
-
Mild 68Ga PSMA-11 Uptake in Incidental Pituitary Adenoma
Molecular imaging and radionuclide therapy, 2022
DOI 10.4274/mirt.galenos.2021.97752 PMID 36268938 4 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC
-
Multiple Subcutaneous 18F-FDG-avid Granulomas Due to Enoxaparin Injection
Molecular imaging and radionuclide therapy, 2022
DOI 10.4274/mirt.galenos.2021.87487 PMID 35771074 Texte intégral en libre accèsSource : Europe PMC
-
Two Cases of Acrometastasis from Lung Cancer Revealed on 18F-FDG PET/CT
Molecular imaging and radionuclide therapy, 2022
DOI 10.4274/mirt.galenos.2021.16013 PMID 35771075 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC
-
Prognostic Significance of 18F-FDG PET/CT Imaging in Survival Outcomes in Patients with Renal Cell Carcinoma
Molecular imaging and radionuclide therapy, 2022
DOI 10.4274/mirt.galenos.2022.42744 PMID 36268871 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC
-
Gallbladder Involvement of Diffuse Large B-Cell Lymphoma with 18F-FDG PET/CT
Turkish journal of haematology : official journal of Turkish Society of Haematology, 2022
DOI 10.4274/tjh.galenos.2020.2020.0693 PMID 33374099 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC
-
Investigation of the Presence of Integrin Alpha-3 and Beta-1 Receptors on Tumor Tissue, Metastatic Lymph Node and Normal Tissue in Thyroid Cancer
Molecular imaging and radionuclide therapy, 2022
DOI 10.4274/mirt.galenos.2021.71501 PMID 35770951 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC